Pregled bibliografske jedinice broj: 49799
Proximal diabetic neuropathy - clinical signs and neurophysiological parameters
Proximal diabetic neuropathy - clinical signs and neurophysiological parameters // Neurodiab VIII - Diabetic Neuropathy Study Group of the EASD : abstracts / Said, G. (ur.).
Sitges: Neurodiab, 1998. str. 78-78 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 49799 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Proximal diabetic neuropathy - clinical signs and neurophysiological parameters
(PROXIMAL DIABETIC NEUROPATHY - CLINICAL SIGNS AND NEUROPHYSIOLOGICAL PARAMETERS)
Autori
Barada, Ante ; Reljanović, Miroslav ; Miličević, Zvonko ; Malik, Rayaz ; Car, Nikica ; Croatian Group for the Study of Proximal Diabetic Neuropathy (Barada, Ante ; Benko, Bojan ; Bilić, Ranko ; Car, Nikica ; Ljubić, Spomenka ; Čavlović Naglić, Maja ; Reljanović, Miroslav ; Metelko, Željko ; Mišur, Irena ; Stenzel, Maja ; Vranešić, Đuro)
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Neurodiab VIII - Diabetic Neuropathy Study Group of the EASD : abstracts
/ Said, G. - Sitges : Neurodiab, 1998, 78-78
Skup
Neurodiab (8 ; 1998(
Mjesto i datum
Sitges, Španjolska, 05.09.1998. - 07.09.1998
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
PDN
Sažetak
The aim of the study was to define the characteristic neurophysiological parameters and clinical signs of proximal diabetic neuropathy (PDN). Twelve patients with PDN (Group 1) and 30 patients with distal symmetric diabetic polyneuropathy (DSDP) but without signs and symptoms of PDN (Group 2) were examined. The groups were comparable with regard to age, gender and diabetes duration. In Group 1 all patients had type 2 diabetes, mean PDN symptoms duration 4.3 + 1.8 months, whereas duration of distal polyneuropathy symptoms in the same patients was 3.2 + 2.3 yrs. Clinical picture in all Group 1 patients was characterised by pronounced pain in the upper legs (mean visual analogue scale value = 7.4 cm), atrophy of upper leg muscles, loss of predominantly pelvifemoral muscle strength and significant weight loss. Bilaterally affected upper legs were recorded in 9 patients and unilateral in 3. Among neurophysiological parameters significant difference between Group 1 and Group 2 was found in motor conduction velocity of femoral nerve (37.3 vs. 61.4 m/s, p<0.0001), while no significant difference was found for peroneal and sural nerves. PDN is present in type 2 diabetics and is characterised by pain, muscle atrophy in upper legs, weight loss and reduced motor conduction velocity of femoral nerve.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
045006
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac